Christoper DelOrefice, who is vice president of investor relations at New Brunswick-based J&J, will join the medical device company — also known as Becton, Dickinson & Co. — effective Sept. 6. He will succeed Christopher Reidy, who is retiring.
“Chris has the right mix of strong operational and corporate finance experience that is highly relevant to his new role as CFO at BD,” Chairman, CEO and President Tom Polen said in a prepared statement. “His deep experience in health care and medical technology — including supporting multiple large businesses and functions at J&J — will help create a seamless transition as CFO.
“His investor relations expertise provides additional value to the investment community who know him well. Chris’ track record leading and developing strong finance teams will be an asset to BD.”
In his new role, DelOrefice will be responsible for running BD’s global finance organization. Reidy also will transition the leadership of BD’s technology & global services organization to DelOrefice by year-end.
“It is an exciting time to be joining BD as it continues to evolve into one of the most relevant global medical technology companies in the world,” DelOrefice said in a statement. “The positive impact on the lives of patients worldwide and its ability to make meaningful progress on some of the most challenging global health issues of our time make BD truly unique in the medical technology industry. I look forward to helping the BD team drive its 2025 growth strategy, optimize its margins and continue to generate shareholder value.”
In nearly two decades with J&J, DelOrefice has held numerous senior financial leadership roles, including serving as CFO of the consumer and medical devices segments for North America.